2025 European guideline on the management of Chlamydia trachomatis infections

Research output: Contribution to journalArticleAcademicpeer-review

36 Downloads (Pure)

Abstract

Sexually transmitted Chlamydia trachomatis infections remain common globally and most frequently are asymptomatic. The 2025 European C. trachomatis guideline provides up-to-date guidance regarding indications for testing and treatment of C. trachomatis infections. It includes advice on urogenital and extragenital C. trachomatis testing including the use of self-collected specimens; recommendation to use only validated NAATs for diagnosis; and recommendation to treat all C. trachomatis infections with doxycycline as first line in preference to single-dose azithromycin regimens. The absence of evidence and limited value of broad screening in asymptomatic populations for C. trachomatis infections is also discussed.
Original languageEnglish
Pages (from-to)434-449
Number of pages16
JournalInternational Journal of Std & Aids
Volume36
Issue number6
Early online date1 Mar 2025
DOIs
Publication statusPublished - May 2025

Keywords

  • <italic>Chlamydia trachomatis</italic>
  • Europe
  • diagnosis
  • treatment
  • antibiotic
  • SEXUALLY-TRANSMITTED INFECTIONS
  • OF-CARE TESTS
  • COMBO 2 ASSAY
  • POLYMERASE-CHAIN-REACTION
  • PENILE-MEATAL SWABS
  • LOW-BIRTH-WEIGHT
  • 1ST VOID URINE
  • NEISSERIA-GONORRHOEAE
  • MYCOPLASMA-GENITALIUM
  • PHARYNGEAL CHLAMYDIA

Fingerprint

Dive into the research topics of '2025 European guideline on the management of Chlamydia trachomatis infections'. Together they form a unique fingerprint.

Cite this